Valiant Laboratories Limited

Valiant Laboratories Limited

Valiant Laboratories Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming that no dematerialization, mutilation, or cancellation of securities was received during the quarter ended June 30, 2026.

Valiant Laboratories Limited

Valiant Laboratories Limited has informed the Exchange regarding the closure of the trading window for its directors, promoters, and other connected persons due to the declaration of financial results for the quarter ended June 30, 2026.

Valiant Laboratories Limited

Valiant Laboratories Limited responds to a clarification sought by the National Stock Exchange of India regarding its financial results for the quarter and year ended March 31, 2025. The company clarifies that its independent auditor's report inadvertently missed a note relating to the balancing figure, as required under the format prescribed by SEBI. The auditor has issued a clarification stating that the financial results include the result for the quarter ended March 31, 2025, being the balancing figure between the audited figures in respect of the full financial year and the published audited year-to-date figure up to the third quarter of the current financial year.